Investors File Lawsuit Against Inovio Pharmaceuticals Over Investments

Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) on behalf of investors who purchased shares of the Company’s stock between February 14, 2020 and March 9, 2020, inclusive (the “Class Period”).

The shareholder class action lawsuit alleges that Inovio made a series of misleading statements to investors about the Company’s development of a purported vaccine for the novel coronavirus, which artificially inflated the value of the Company’s shares during the Class Period and resulted in significant investor losses.

Read the source article at Yahoo Finance

    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button